Muscle Cells: Tailoring the taste of cultured meat
Although the idea of growing meat in a laboratory may seem like science fiction, over a decade has passed since the first synthetic beef burger was unveiled in 2013 (Kupferschmidt, 2013). Moreover, in June 2023, two companies – Upside Foods and GOOD Meat – were granted approval by the Food and Drug Administration (FDA) to sell ‘cultured meat’ products in the United States (Wiener-Bronner, 2023).
While producing meat in a laboratory could eventually lead to a reduction in livestock farming, which would bring benefits in terms of improved animal welfare and reduced environmental impact (Post, 2012), the process is not free from challenges. For instance, there are concerns around food safety, the high cost of production, and whether the public will accept meat that has been artificially made. Also, if the cultured meat does not taste exactly like the real deal, consumers may turn away. Moreover, cultured meat products will have to compete against other, more affordable options, such as plant-based burgers.
A compelling advantage of cultured meat is that its texture, flavor and nutritional content can be tailored during production (Broucke et al., 2023). Lab-grown meat is made by isolating cells from the tissue of a live animal or fertilized egg, and differentiating them into muscle, fat and connective tissue. By altering the composition of cells generated during this process, researchers could make lab-grown meat that is personalized to an individual’s taste. However, combining and co-culturing the different source cells needed to produce these three components is no easy task. Now, in eLife, Hen Wang and co-workers – including Tongtong Ma, Ruimin Ren and Jianqi Lv as joint first authors – report an innovative approach for customizing cultured meat using just fibroblasts from chickens (Ma et al., 2024; Figure 1).
First, the team (who are based at Shandong Agricultural University and Huazhong Agricultural University) optimized the culture conditions for the chicken fibroblasts. This included changing the composition of the medium the cells were fed, and developing a three-dimensional environment, made of a substance called hydrogel, that the fibroblasts could grow and differentiate in. Ma et al. then used a previously established protocol to activate the gene for a protein called MyoD, which induces fibroblasts to transform into muscle cells (Ren et al., 2022). Importantly, the resulting muscle cells exhibited characteristics of healthy muscle cells and were distinct from muscle cells that appear during injury.
While muscle is a fundamental component of meat, the inclusion of fat and extracellular matrix proteins is essential for enhancing flavor and texture (Fraeye et al., 2020). To stimulate the formation of fat deposits between the muscle cells, the differentiated chicken muscle cells were exposed to fatty acids and insulin. This caused the cells to produce lipid droplets, signifying that the process of fat synthesis had been initiated. Measuring the level of the lipid triglyceride revealed that the fat content of the cultured fibroblasts was comparable to that in real chicken meat, and even climbed two to three times higher when insulin levels were increased.
Ma et al. then validated that the chicken fibroblasts were also able to produce various extracellular matrix proteins found in connective tissue. This is critical for forming edible cultured meat products as the tissue surrounding muscle cells gives meat its texture and structural integrity.
The study by Ma et al. underscores the potential for modulating key components (such as muscle, fat, and extracellular matrix proteins) to produce high quality lab-grown meat that is palatable to consumers. It also demonstrates how the important components of meat can be produced from just a single source of fibroblasts, rather than mixing multiple cell types together. As this is a proof-of-concept study, many of the issues associated with producing cultured meat for a mass market still persist. These include the high cost of components such as insulin, and concerns around the use of genetically modified cells: moreover, potentially toxic chemicals are required to activate the gene for MyoD.
Nevertheless, advancements in biotechnology, coupled with the recent FDA approval for genetically modified cells in lab-grown meat production (Martins et al., 2024), signal a promising future for the cultured-meat market. In the future, genetic, chemical and physical interventions may be used to precisely design other bioactive compounds found in meat, in addition to fat and muscle (Jairath et al., 2024). It may not be long until personalized cultured meat products with finely-tuned flavors, textures, and nutrients are available for sale.
References
-
Bioactive compounds in meat: Their roles in modulating palatability and nutritional valueMeat and Muscle Biology 8:16992.https://doi.org/10.22175/mmb.16992
-
Advances and challenges in cell biology for cultured meatAnnual Review of Animal Biosciences 12:345–368.https://doi.org/10.1146/annurev-animal-021022-055132
Article and author information
Author details
Publication history
Copyright
© 2024, Jin and Bao
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 1,170
- views
-
- 107
- downloads
-
- 2
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Further reading
-
- Cell Biology
Expansion microscopy (ExM) enables nanoscale imaging using a standard confocal microscope through the physical, isotropic expansion of fixed immunolabeled specimens. ExM is widely employed to image proteins, nucleic acids, and lipid membranes in single cells; however, current methods limit the number of samples that can be processed simultaneously. We developed High-throughput Expansion Microscopy (HiExM), a robust platform that enables expansion microscopy of cells cultured in a standard 96-well plate. Our method enables ~4.2 x expansion of cells within individual wells, across multiple wells, and between plates. We also demonstrate that HiExM can be combined with high-throughput confocal imaging platforms to greatly improve the ease and scalability of image acquisition. As an example, we analyzed the effects of doxorubicin, a known cardiotoxic agent, on human cardiomyocytes (CMs) as measured by the Hoechst signal across the nucleus. We show a dose-dependent effect on nuclear DNA that is not observed in unexpanded CMs, suggesting that HiExM improves the detection of cellular phenotypes in response to drug treatment. Our method broadens the application of ExM as a tool for scalable super-resolution imaging in biological research applications.
-
- Cell Biology
- Developmental Biology
Eukaryotic cells depend on exocytosis to direct intracellularly synthesized material toward the extracellular space or the plasma membrane, so exocytosis constitutes a basic function for cellular homeostasis and communication between cells. The secretory pathway includes biogenesis of secretory granules (SGs), their maturation and fusion with the plasma membrane (exocytosis), resulting in release of SG content to the extracellular space. The larval salivary gland of Drosophila melanogaster is an excellent model for studying exocytosis. This gland synthesizes mucins that are packaged in SGs that sprout from the trans-Golgi network and then undergo a maturation process that involves homotypic fusion, condensation, and acidification. Finally, mature SGs are directed to the apical domain of the plasma membrane with which they fuse, releasing their content into the gland lumen. The exocyst is a hetero-octameric complex that participates in tethering of vesicles to the plasma membrane during constitutive exocytosis. By precise temperature-dependent gradual activation of the Gal4-UAS expression system, we have induced different levels of silencing of exocyst complex subunits, and identified three temporarily distinctive steps of the regulated exocytic pathway where the exocyst is critically required: SG biogenesis, SG maturation, and SG exocytosis. Our results shed light on previously unidentified functions of the exocyst along the exocytic pathway. We propose that the exocyst acts as a general tethering factor in various steps of this cellular process.